US Stock MarketDetailed Quotes
LGND Ligand Pharmaceuticals
- 101.140
- -2.010-1.95%
Close Sep 6 16:00 ET
- 101.140
- 0.0000.00%
Post 16:02 ET
1.85BMarket Cap43.41P/E (TTM)
104.890High99.080Low64.66KVolume103.580Open103.150Pre Close6.54MTurnover0.36%Turnover Ratio34.40P/E (Static)18.27MShares112.12552wk High2.38P/B1.81BFloat Cap49.24052wk Low--Dividend TTM17.89MShs Float173.736Historical High--Div YieldTTM5.63%Amplitude4.115Historical Low101.102Avg Price1Lot Size
Ligand Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 16,336.59%13.31M | -44.82%18.73M | -64.04%49.58M | -84.92%8.07M | -62.68%7.65M | -100.69%-82K | -34.73%33.95M | 74.94%137.85M | 93.44%53.47M | 2.32%20.49M |
| Net income from continuing operations | -2,366.86%-51.91M | 105.34%86.14M | 256.33%52.15M | 204.02%18.19M | -2,642.82%-10.27M | 355.87%2.29M | 372.66%41.95M | -158.39%-33.36M | -222.84%-17.49M | -97.06%404K |
| Operating gains losses | 620.82%20.79M | -174.75%-108.62M | -43.31%-46.91M | 67.35%-14.45M | 19,308.77%11.06M | -3,570.43%-3.99M | -448.46%-39.53M | -389.66%-32.73M | -464.73%-44.25M | 103.15%57K |
| Depreciation and amortization | -6.76%8.85M | -7.73%8.77M | -30.62%35.64M | -19.88%8.92M | -42.78%7.73M | -27.45%9.5M | -30.38%9.5M | 0.83%51.37M | -14.01%11.13M | 7.07%13.51M |
| Deferred tax | -106.66%-20.67M | 123.28%19.55M | -43.56%11.7M | -89.34%4.94M | 163.32%8.01M | -407.22%-10M | 154.10%8.75M | 340.46%20.72M | 12,000.51%46.29M | -922.71%-12.65M |
| Other non cash items | 27.53%982K | -844.57%-2.52M | -58.29%2.45M | -66.43%712K | -19.29%1.23M | -49.38%770K | -138.09%-267K | 142.37%5.87M | -75.48%2.12M | 294.53%1.53M |
| Change In working capital | -38.97%-7.61M | 4.38%8.24M | -152.38%-34.4M | -160.18%-15.99M | -515.73%-20.83M | 62.74%-5.48M | -83.81%7.9M | 215.21%65.68M | 349.36%26.57M | 133.31%5.01M |
| -Change in receivables | -757.15%-9.05M | 215.01%3.46M | -104.70%-2.6M | -91.85%2.84M | -197.67%-7.91M | 106.74%1.38M | -97.48%1.1M | 293.31%55.32M | 275.80%34.77M | 56.98%-2.66M |
| -Change in inventory | 119.14%2.49M | 29.34%2.63M | -190.15%-10.87M | -47.86%707K | -163.51%-611K | -234.09%-13M | 4,525.00%2.04M | 2,923.89%12.06M | -49.33%1.36M | 223.81%962K |
| -Change in payables and accrued expense | 139.16%1.77M | -217.70%-1.38M | -40.84%-4.7M | 193.94%2.76M | -163.28%-2.5M | -174.41%-4.53M | 83.94%-435K | -218.86%-3.34M | -145.54%-2.94M | 460.57%3.95M |
| -Change in other working capital | -126.44%-2.82M | -32.07%3.53M | -1,089.45%-16.23M | -222.11%-21.37M | -486.94%-10.73M | 561.24%10.67M | -33.50%5.2M | 105.33%1.64M | -663,600.00%-6.64M | 131.53%2.77M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 16,336.59%13.31M | -44.82%18.73M | -64.04%49.58M | -84.92%8.07M | -62.68%7.65M | -100.69%-82K | -34.73%33.95M | 74.94%137.85M | 93.44%53.47M | 2.32%20.49M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -824.71%-54.76M | -135.79%-3.78M | -107.14%-11.68M | -41.19%-10.28M | -201.71%-19.5M | -80.04%7.56M | -90.74%10.55M | 436.07%163.62M | 79.60%-7.28M | 205.26%19.18M |
| Net PPE purchase and sale | -100.99%-408K | 95.65%-105K | 80.35%-3.52M | 80.43%-417K | 88.75%-487K | 96.92%-203K | 50.48%-2.41M | -104.58%-17.92M | 2.92%-2.13M | -144.30%-4.33M |
| Net intangibles purchase and sale | 543.37%534K | -485.38%-501K | -54,350.00%-49.91M | -4,877.47%-50.26M | 114.17%136K | --83K | --130K | -81.38%92K | 112.96%1.05M | ---960K |
| Net business purchase and sale | ---75M | ---998K | -3,320.53%-25.65M | ---14K | ---25.64M | --0 | --0 | ---750K | --0 | --0 |
| Net investment purchase and sale | 194.62%22.62M | -116.92%-2.17M | -63.20%67.4M | 882.30%40.41M | -73.43%6.49M | -82.71%7.68M | -89.26%12.83M | 357.80%183.17M | 84.18%-5.17M | 248.48%24.42M |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 21.31%-960K | 23.25%-1.04M | --47K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -824.71%-54.76M | -135.79%-3.78M | -107.14%-11.68M | -41.19%-10.28M | -201.71%-19.5M | -80.04%7.56M | -90.74%10.55M | 436.07%163.62M | 79.60%-7.28M | 205.26%19.18M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 114.01%9.49M | 1,671.87%12.18M | 78.28%-59.95M | 200.32%5.32M | 108.01%3.27M | -13.99%-67.76M | 99.55%-775K | -100.34%-275.99M | -227.23%-5.3M | -10,504.94%-40.83M |
| Net issuance payments of debt | 99.99%-4K | 61.54%-5K | 70.54%-76.9M | 16.67%-45K | 100.07%26K | -28.25%-76.87M | 99.99%-13K | -58.23%-261M | ---54K | -1,482.43%-37.65M |
| Proceeds from stock option exercised by employees | 4.48%9.55M | 351.05%15.3M | 594.55%22.45M | 365.81%6.53M | 313.05%3.39M | 1,276.81%9.14M | 877.81%3.39M | -90.43%3.23M | -67.26%1.4M | -56.84%820K |
| Net other financing activities | -78.13%-57K | 24.98%-3.12M | 69.83%-5.5M | 82.45%-1.17M | 96.43%-143K | 81.40%-32K | 43.84%-4.16M | -177.05%-18.22M | -5,678.26%-6.65M | -4,358.51%-4M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 114.01%9.49M | 1,671.87%12.18M | 78.28%-59.95M | 200.32%5.32M | 108.01%3.27M | -13.99%-67.76M | 99.55%-775K | -100.34%-275.99M | -227.23%-5.3M | -10,504.94%-40.83M |
| Net cash flow | ||||||||||
| Beginning cash position | -43.54%50.09M | -49.00%22.95M | 130.54%45.01M | 382.46%19.86M | 438.73%28.45M | 491.80%88.73M | 130.54%45.01M | -59.30%19.52M | -82.43%4.12M | -76.01%5.28M |
| Current changes in cash | 46.99%-31.95M | -37.93%27.14M | -186.53%-22.05M | -92.43%3.1M | -637.71%-8.59M | -520.64%-60.28M | 1,065.38%43.72M | 189.61%25.48M | 1,146.58%40.89M | -181.80%-1.16M |
| End cash Position | -36.23%18.14M | -43.54%50.09M | -49.00%22.95M | -49.00%22.95M | 382.46%19.86M | 438.73%28.45M | 491.80%88.73M | 130.54%45.01M | 130.54%45.01M | -82.43%4.12M |
| Free cash flow | 4,021.05%11.18M | -48.68%16.18M | -103.56%-4.27M | -181.60%-42.68M | -52.90%7.16M | -105.39%-285K | -33.10%31.53M | 71.23%119.93M | 105.53%52.3M | -16.73%15.2M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg